Insider filing · GH
AmirAli Talasaz
Co-Chief Executive Officer
profile →
Guardant Health, Inc.
GH · Healthcare · 57 filings in 24 months
ticker →
AmirAli Talasaz sold $10.5M of Guardant Health (GH)
Executed Dec 8 2025, disclosed Dec 10 2025, 2 days later.
Value, as filed
$10.5M
100,000 sh across 6 lots
Executed
Dec 8 2025
the trade date, as filed
Disclosed
Dec 10 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
ATAmirAli Talasaz (Co-Chief Executive Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Guardant Health, Inc. (GH). The largest single filing was $39.3M of GH (259,960 sh across 5 lots, as filed), executed Jun 26.
The name
GHHealthcare · Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by AmirAli Talasaz in GH
GHSALE
Guardant Health, Inc.
$6.3M37,500 sh across 3 lots
Exec Aug 21
Filed Aug 24 · 5:21 PM ET GHSALE Guardant Health, Inc. $39.3M
259,960 sh across 5 lots
Exec Jun 26
Filed Jun 30 · 5:30 PM ET GHSALE Guardant Health, Inc. $23.0M
208,900 sh across 10 lots
Exec May 20
Filed May 22 · 5:30 PM ET GHSALE Guardant Health, Inc. $5.0M
50,000 sh × $100.32
Exec May 12
Filed May 13 · 5:30 PM ET GHSALE Guardant Health, Inc. $5.1M
100,000 sh across 2 lots
Exec Jul 1 2025
Filed Jul 2 2025 · 5:30 PM ET GHSALE Guardant Health, Inc. $5.9M
117,604 sh across 2 lots
Exec Jun 6 2025
Filed Jun 9 2025 · 5:30 PM ET GHSALE Guardant Health, Inc. $5.8M
118,614 sh across 5 lots
Exec May 1 2025
Filed May 5 2025 · 5:30 PM ET